The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis
Clinical trial NCT02632786 · COMPLETED
Trial details
- NCT number
- NCT02632786
- Sponsor
- Prothena Biosciences Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2018-03-01
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.